Sarah E. Ferguson
University Health Network, University of Toronto, Princess Margaret Cancer Centre
Papers
10
Total Citations
717
H-Index
9
About
Dr. Sarah E. Ferguson is a leading gynecologic oncologist whose research has fundamentally reshaped surgical standards for endometrial and cervical cancers. Her work centers on optimizing surgical approaches—from sentinel lymph node biopsy to minimally invasive techniques—to improve oncologic outcomes while reducing patient morbidity. Her landmark 2020 study in *JAMA Oncology* (224 citations) provided pivotal evidence that sentinel lymph node biopsy can safely replace full lymphadenectomy for staging high-grade endometrial cancer, changing clinical practice. She has also critically evaluated the impact of surgical approach on survival, notably investigating whether intra-uterine manipulators contribute to poorer outcomes in minimally invasive cervical cancer surgery. Dr. Ferguson’s meta-analyses on hysterectomy in obese patients (159 citations) and radical hysterectomy for cervical cancer (139 citations) are widely cited. She is a principal investigator in the international SHAPE trial, a phase III study comparing radical versus simple hysterectomy for low-risk cervical cancer, which has the potential to de-escalate treatment. Her prospective work on patient-reported outcomes and cost-effectiveness further underscores her commitment to holistic, evidence-based care. With over 800 citations across her top papers, Dr. Ferguson is a transformative figure in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10Reply2 citations · 2019